Clinical Trial Detail

NCT ID NCT02260440
Title A Phase 2 Study of MK-3475 in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors University of Pittsburgh
Indications

colorectal cancer

Therapies

Azacitidine + Pembrolizumab

Age Groups: adult

No variant requirements are available.